AKT1 and Insulin resistance: The synergy between both supplements on insulin sensitivity most likely arises from complementary targeting of insulin resistance and reduction in adiposity, since both enhance PI3K/Akt activation in the liver and skeletal muscle and mitigate adiposity and adipose tissue inflammation.